BioMarin Pharmaceutical Inc. buy Truist Financial Co.
Start price
25.09.23
/
50%
€83.00
Target price
25.09.24
€131.92
Performance (%)
-7.25%
Price
10.09.24
€76.98
Summary
This prediction is currently active. With a performance of -7.25%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 25.09.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -7.208% | -7.208% |
iShares Core DAX® | -1.611% | 3.135% |
iShares Nasdaq 100 | -0.500% | 0.775% |
iShares Nikkei 225® | -1.483% | 4.610% |
iShares S&P 500 | -0.501% | 1.914% |
Comments by Truist_Financial_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $140.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€106.35
05.09.25
05.09.25
2.01%
10.09.24
10.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€82.68
15.09.23
15.09.23
€131.12
15.09.24
15.09.24
-6.89%
10.09.24
10.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€125.20
13.07.24
13.07.24
3.31%
14.07.24
14.07.24